SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$260M

Amount

Series B

Stage

16.07.2024

Date

3

all rounds

$603.15M

Total amount

date founded

Financing round

General

About Company
Cardurion is a biotechnology company that develops therapeutics for cardiovascular diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

founders

Number of employees

11-50

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company has partnerships with Takeda and Astellas to develop novel treatments for heart failure, including CRD-733, a PDE-9 inhibitor that has shown potential to improve cardiac function. Cardurion's experienced team of cardiovascular experts and industry veterans take a strategic portfolio approach to drug discovery, with in-house programs and foundational partnerships with key investors. The company has facilities in Massachusetts and Japan.
Contacts

location

Boston, MA, USA

Contact Email

Phone number

Website URL

http://cardurion.com/

Social url

Legal Names

Legal name

Cardurion Pharmaceuticals LLC
Similar Companies
999
Cardiorentis
CardiorentisCardiorentis is a biopharmaceutical company focused on developing novel therapies for heart failure and related cardiovascular diseases.
Cardiorentis

Cardiorentis

Cardiorentis is a biopharmaceutical company focused on developing novel therapies for heart failure and related cardiovascular diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Zug, Switzerland

total rounds

2

total raised

$118.48M
Nuvelo
NuveloNuvelo, Inc. is a publicly traded company.
Nuvelo

Nuvelo

Nuvelo, Inc. is a publicly traded company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Carlos, CA, USA
Amarin Pharma
Amarin PharmaAmarin Corporation plc develops cardiovascular therapeutics to improve heart health.
Amarin Pharma

Amarin Pharma

Amarin Corporation plc develops cardiovascular therapeutics to improve heart health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Bridgewater Township, NJ, USA
MyoKardia
MyoKardiaMyoKardia develops targeted therapies for rare cardiovascular diseases.
MyoKardia

MyoKardia

MyoKardia develops targeted therapies for rare cardiovascular diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Brisbane, CA, USA

total rounds

5

total raised

$98M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$603.15M

Money Raised

Their latest funding was raised on 16.07.2024. Their latest investor Bain Capital Private Equity. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.07.2024
Series B
10
$260M
—
30.12.2022
Debt Financing
—
$17.5M
—
27.10.2021
Venture - Series Unknown
3
$300M
—
Co-Investors
Investors
13
0

Number of lead investors

13

Number of investors

Investor 
Lead 
Round 
Partners 
Bain Capital Private Equity
Bain Capital Private Equity
No
Series B
—
Blue Owl
Blue Owl
No
Series B
—
Delos Capital
Delos Capital
No
Series B
—
Bain Capital Private Equity

Bain Capital Private Equity

This company is a venture capital firm based in the UK, with a focus on investing in healthcare and pharmaceutical startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

London, UK

count Of Investments

20

count Of Exists

4
Blue Owl

Blue Owl

Blue Owl Capital provides investors access to direct lending and GP capital solutions strategies through a variety of vehicles.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Consulting

Location

New York, NY, USA

total rounds

4

total raised

$2.9B

count Of Investments

24

count Of Exists

1
Delos Capital

Delos Capital

Delos Capital is a private equity investment firm based in New York City.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

New York, NY, USA

count Of Investments

27

People

Founders
1
Michael Mendelsohn
Michael Mendelsohn

Michael Mendelsohn

Michael Mendelsohn is the Founder and Chairman of Cardurion Pharmaceuticals. Michael Mendelsohn attended Harvard Medical School.

current job

Cardurion Pharmaceuticals
Cardurion Pharmaceuticals
Michael Mendelsohn

Michael Mendelsohn

Employee Profiles
7
Elizabeth Radcliffe
Elizabeth Radcliffe

Elizabeth Radcliffe

Chief Financial Officer

Chief Financial Officer

Howard Surks
Howard Surks

Howard Surks

Chief Medical Officer and Head of Translational Medicine

Chief Medical Officer and Head of Translational Medicine

Christopher Morabito
Christopher Morabito

Christopher Morabito

Chief Medical Officer

Chief Medical Officer

Steven Luperchio

Steven Luperchio

Executive director, program management

Executive director, program management

Paula Goldberg

Paula Goldberg

Contracts consultant

Contracts consultant

Rebecca Velez Frey
Rebecca Velez Frey

Rebecca Velez Frey

Chief Operating Officer

Chief Operating Officer

Michael Mendelsohn
Michael Mendelsohn

Michael Mendelsohn

Founder & Chairman

Founder & Chairman

Activity

Recent News
6
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month